Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

Increasing incidence of empyema complicating childhood community-acquired pneumonia in the United States.

Grijalva CG, Nuorti JP, Zhu Y, Griffin MR.

Clin Infect Dis. 2010 Mar 15;50(6):805-13. doi: 10.1086/650573.

2.

Empyema hospitalizations increased in US children despite pneumococcal conjugate vaccine.

Li ST, Tancredi DJ.

Pediatrics. 2010 Jan;125(1):26-33. doi: 10.1542/peds.2009-0184. Epub 2009 Nov 30. Erratum in: Pediatrics. 2010 Feb;125(2):415.

PMID:
19948570
3.

Pneumonia hospitalizations among young children before and after introduction of pneumococcal conjugate vaccine--United States, 1997-2006.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2009 Jan 16;58(1):1-4.

4.

Prevalence of occult bacteremia in children aged 3 to 36 months presenting to the emergency department with fever in the postpneumococcal conjugate vaccine era.

Wilkinson M, Bulloch B, Smith M.

Acad Emerg Med. 2009 Mar;16(3):220-5. doi: 10.1111/j.1553-2712.2008.00328.x. Epub 2008 Dec 13.

5.

Five-fold increase in pediatric parapneumonic empyema since introduction of pneumococcal conjugate vaccine.

Hendrickson DJ, Blumberg DA, Joad JP, Jhawar S, McDonald RJ.

Pediatr Infect Dis J. 2008 Nov;27(11):1030-2. doi: 10.1097/INF.0b013e31817e5188.

PMID:
18845981
6.

Identification of pneumococcal serotypes from culture-negative clinical specimens by novel real-time PCR.

Tarragó D, Fenoll A, Sánchez-Tatay D, Arroyo LA, Muñoz-Almagro C, Esteva C, Hausdorff WP, Casal J, Obando I.

Clin Microbiol Infect. 2008 Sep;14(9):828-34. doi: 10.1111/j.1469-0691.2008.02028.x.

7.

Pediatric parapneumonic empyema, Spain.

Obando I, Muñoz-Almagro C, Arroyo LA, Tarrago D, Sanchez-Tatay D, Moreno-Perez D, Dhillon SS, Esteva C, Hernandez-Bou S, Garcia-Garcia JJ, Hausdorff WP, Brueggemann AB.

Emerg Infect Dis. 2008 Sep;14(9):1390-7. doi: 10.3201/eid1409.071094.

8.

Impact of the introduction of pneumococcal conjugate vaccine on rates of community acquired pneumonia in children and adults.

Nelson JC, Jackson M, Yu O, Whitney CG, Bounds L, Bittner R, Zavitkovsky A, Jackson LA.

Vaccine. 2008 Sep 8;26(38):4947-54. doi: 10.1016/j.vaccine.2008.07.016. Epub 2008 Jul 26.

PMID:
18662735
9.

Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States.

Tsai CJ, Griffin MR, Nuorti JP, Grijalva CG.

Clin Infect Dis. 2008 Jun 1;46(11):1664-72. doi: 10.1086/587897.

10.

Health care utilization for pneumonia in young children after routine pneumococcal conjugate vaccine use in the United States.

Zhou F, Kyaw MH, Shefer A, Winston CA, Nuorti JP.

Arch Pediatr Adolesc Med. 2007 Dec;161(12):1162-8.

PMID:
18056561
11.

Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.

Hicks LA, Harrison LH, Flannery B, Hadler JL, Schaffner W, Craig AS, Jackson D, Thomas A, Beall B, Lynfield R, Reingold A, Farley MM, Whitney CG.

J Infect Dis. 2007 Nov 1;196(9):1346-54. Epub 2007 Oct 4.

PMID:
17922399
12.

Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumococcal conjugate vaccine.

Black S, France EK, Isaacman D, Bracken L, Lewis E, Hansen J, Fireman B, Austrian R, Graepel J, Gray S, Klein NP.

Pediatr Infect Dis J. 2007 Sep;26(9):771-7.

PMID:
17721369
13.

Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005.

Messina AF, Katz-Gaynor K, Barton T, Ahmad N, Ghaffar F, Rasko D, McCracken GH Jr.

Pediatr Infect Dis J. 2007 Jun;26(6):461-7.

PMID:
17529859
14.

Changing characteristics of invasive pneumococcal disease in Metropolitan Atlanta, Georgia, after introduction of a 7-valent pneumococcal conjugate vaccine.

Albrich WC, Baughman W, Schmotzer B, Farley MM.

Clin Infect Dis. 2007 Jun 15;44(12):1569-76. Epub 2007 May 8.

PMID:
17516400
15.

Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage.

Singleton RJ, Hennessy TW, Bulkow LR, Hammitt LL, Zulz T, Hurlburt DA, Butler JC, Rudolph K, Parkinson A.

JAMA. 2007 Apr 25;297(16):1784-92.

PMID:
17456820
16.

Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis.

Grijalva CG, Nuorti JP, Arbogast PG, Martin SW, Edwards KM, Griffin MR.

Lancet. 2007 Apr 7;369(9568):1179-86.

PMID:
17416262
17.

Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine.

Poehling KA, Talbot TR, Griffin MR, Craig AS, Whitney CG, Zell E, Lexau CA, Thomas AR, Harrison LH, Reingold AL, Hadler JL, Farley MM, Anderson BJ, Schaffner W.

JAMA. 2006 Apr 12;295(14):1668-74.

PMID:
16609088
18.

Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae.

Kyaw MH, Lynfield R, Schaffner W, Craig AS, Hadler J, Reingold A, Thomas AR, Harrison LH, Bennett NM, Farley MM, Facklam RR, Jorgensen JH, Besser J, Zell ER, Schuchat A, Whitney CG; Active Bacterial Core Surveillance of the Emerging Infections Program Network.

N Engl J Med. 2006 Apr 6;354(14):1455-63. Erratum in: N Engl J Med. 2006 Aug 10;355(6):638.

19.

Prior pneumococcal vaccination is associated with reduced death, complications, and length of stay among hospitalized adults with community-acquired pneumonia.

Fisman DN, Abrutyn E, Spaude KA, Kim A, Kirchner C, Daley J.

Clin Infect Dis. 2006 Apr 15;42(8):1093-101. Epub 2006 Mar 13.

PMID:
16575726
20.

Changing epidemiology of outpatient bacteremia in 3- to 36-month-old children after the introduction of the heptavalent-conjugated pneumococcal vaccine.

Herz AM, Greenhow TL, Alcantara J, Hansen J, Baxter RP, Black SB, Shinefield HR.

Pediatr Infect Dis J. 2006 Apr;25(4):293-300.

PMID:
16567979

Supplemental Content

Support Center